- Report
- October 2023
- 146 Pages
Global
From €3762EUR$4,150USD£3,255GBP
- Report
- November 2024
- 116 Pages
Global
From €3500EUR$4,136USD£3,134GBP
- Report
- November 2024
- 109 Pages
Global
From €3500EUR$4,136USD£3,134GBP
- Report
- November 2024
- 141 Pages
Global
From €3500EUR$4,136USD£3,134GBP
- Report
- November 2024
- 127 Pages
Global
From €3500EUR$4,136USD£3,134GBP
The Enzyme Linked Immunosorbent Assay (ELISA) Test is a type of In Vitro Diagnostics (IVD) test used to detect and measure the presence of antibodies, antigens, and other proteins in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of hormones, toxins, and other substances in the body.
The ELISA Test market is a rapidly growing segment of the IVD market. ELISA tests are used in a variety of clinical settings, including hospitals, laboratories, and research facilities. The market is driven by the increasing demand for accurate and reliable diagnostic tests, as well as the development of new technologies and products.
Some of the major companies in the ELISA Test market include Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more